Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2025-12-26 @ 4:09 AM
Study NCT ID:
NCT01276327
Status:
COMPLETED
Last Update Posted:
2014-06-09
First Post:
2011-01-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01
Start Date Type:
None
Primary Completion Date:
2011-05
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2011-01-12
First Submit QC Date:
None
Study First Post Date:
2011-01-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-03-12
Results First Submit QC Date:
None
Results First Post Date:
2014-04-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-03
Last Update Post Date:
2014-06-09
Last Update Post Date Type:
ESTIMATED